A 50-year experience with autoimmune hepatitis: And where are we now?

Journal of Gastroenterology

Volumn 46, Issue SUPPL. 1, 2011, Pages 17-28

  MacKay, Ian R ^a  

^a NONE

Author keywords

Autoantibodies; Autoimmune hepatitis; Deconstruction of autoimmunity; Diagnostic criteria; Immunosuppressive therapy

Indexed keywords

ACTIN ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIGEN; AZATHIOPRINE; CORTISONE; CYTOCHROME P450 2D6; DEAMINASE; FORMIMINOTRANSFERASE CYCLODEAMINASE; HEPATITIS B SURFACE ANTIGEN; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; IMMUNOGLOBULIN G4; LIVER CYTOSOL ANTIGEN 1; LIVER KIDNEY MICROSOMEAL ANTIBODY; MERCAPTOPURINE; MICROSOME ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PLACEBO; PREDNISOLONE; SMOOTH MUSCLE ANTIBODY; SOLUBLE LIVER PANCREAS ANTIGEN; TISSUE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CHRONIC ACTIVE HEPATITIS; COMBINATION CHEMOTHERAPY; COMPLEMENT FIXATION TEST; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DRUG DOSE REDUCTION; DRUG EFFICACY; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; LIVER BIOPSY; LIVER DISEASE; LONG TERM CARE; LOW DRUG DOSE; LUPOID HEPATITIS; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; TREATMENT DURATION;

AGE FACTORS; ANTIBODIES, ANTINUCLEAR; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SEX FACTORS;

EID: 78651373623     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0325-2     Document Type: Article

References (85)

1. IR Mackay 2008 Historical reflections on autoimmune hepatitis World J Gastroenterol 14 3292 3300 10.3748/wjg.14.3292 18528926
2. IJ Wood WE King PJ Parsons JW Perry M Freeman L Lim-Brick 1948 Non-suppurative hepatitis: a study of acute and chronic forms with special reference to biochemical and histological changes Med J Aust 1 249 261 1:STN:280:DyaH1c%2Fgs1ahug%3D%3D 18862481
3. Himsworth HP. Lectures on the liver and its diseases. Oxford: Blackwell; 1947. p. 158-61.
4. KG Stern M Reiner 1946 Electrophoresis in medicine Yale J Biol Med 19 67 99 1:STN:280:DyaH2s%2FjslagtQ%3D%3D 20275723
5. HJ Zimmerman P Heller RP Hill 1951 Extreme hyperglobulinemia in subacute hepatic necrosis N Engl J Med 244 245 249 1:CAS:528:DyaG3MXls1Ohug%3D%3D 10.1056/NEJM195102152440702 14796822
6. HG Kunkel EH Ahrens WJ Eisenmenger AM Bongiovanni RJ Slater 1951 Extreme hypergammaglobulinemia in young women with liver disease J Clin Invest 30 654
7. JM Neefe 1946 Recent advances in the knowledge of 'virus hepatitis' Med Clin North Am 39 1407 1443
8. RB Capps 1948 Clinical aspects of the sequelae of acute hepatitis Gastroenterology 11 680 684 1:STN:280:DyaH1M%2FgtFygtg%3D%3D 18100238
9. AR Page RA Good 1960 Plasma cell hepatitis with special attention to steroid therapy J Dis Child 99 288 314 1:STN:280:DyaF3c7ot1CltA%3D%3D
10. EG Saint WE King RA Joske ES Finckh 1953 The course of infectious hepatitis with special reference to prognosis and the chronic stage Australas Ann Med 2 113 127 1:STN:280:DyaG2c%2Fjs1amtw%3D%3D 13115293
11. Joske RA, King WE. The "L.E. Cell" phenomenon in active chronic viral hepatitis. Lancet. 1955;ii:477-80.
12. MM Hargraves H Richmond R Morton 1948 Presentation of two bone marrow elements: the "tart" cell and the "L.E". cell Proc Staff Meet Mayo Clin 23 25 28 1:STN:280:DyaH1c%2FmsVyruw%3D%3D
13. JR Haserick L Lewis DW Bortz 1950 Blood factor in acute disseminated lupus erythematosus: 1. Determination of gamma globulin as specific plasma fraction Am J Med Sci 20 660 664 10.1097/00000441-195006000-00010
14. Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet. 1956;ii:1323-6.
15. IR Mackay 1961 The problem of persisting destructive disease of the liver Gastroenterology 40 617 626 1:STN:280:DyaF3c%2FosVymtg%3D%3D 13764879
16. A Reuben 2003 A sheep in wolf's clothing Hepatology 38 1596 1601 10.1002/hep.510380643 14647073
17. IR Mackay DC Gajdusek 1958 An autoimmune reaction against human tissue antigens in certain acute and chronic diseases: II. Clinical correlation Arch Intern Med 101 30 46 1:STN:280:DyaG1c%2FivFKlsg%3D%3D
18. Holbrow EJ, Asherson GL, Johnson GD, Barnes RDS, Carmichael PS. Antinuclear factor and other antibodies in blood and liver diseases. Br Med J. 1963;i:656-8.
19. IR Mackay S Weiden J Hasker 1965 Autoimmune hepatitis Ann N Y Acad Sci 24 767 780
20. PJ Johnson IG McFarlane 1993 Meeting report: International Autoimmune Hepatitis Group Hepatology 18 998 1005 1:STN:280:DyaK2c%2FhtVOksg%3D%3D 10.1002/hep.1840180435 8406375
21. RD Soloway DM Summerskill AH Baggenstoss LJ Shoenfield 1972 'Lupoid' hepatitis, a non-entity in the spectrum of chronic active liver disease Gastroenterology 63 458 465 1:STN:280:DyaE3s%2FgsFantQ%3D%3D 4116064
22. Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet. 1959;i 65-9.
23. Johnson GD, Holborow EJ, Glynn LE. Antibody to smooth muscle in patients with liver disease. Lancet. 1965;ii:878-9.
24. S Whittingham J Irwin IR Mackay M Smalley 1966 Smooth muscle autoantibody in 'autoimmune' hepatitis Gastroenterology 51 499 505 1:STN:280: DyaF2s%2FktFyqsg%3D%3D 5332194
25. Whittingham S, Mackay IR, Irwin J. Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet. 1966;i:1333-5.
26. Johnson GD, Holborow EJ, Glynn LE. Antibody to liver in lupoid hepatitis. Lancet. 1966;ii:416-8.
27. GF Bottazzo A Florin-Christensen A Fairfax G Swana D Doniach U Groeschel-Stewart 1976 Classification of smooth muscle autoantibodies detected by immunofluorescence J Clin Pathol 29 403 410 1:STN:280:DyaE283htlOhuw%3D%3D 10.1136/jcp.29.5.403 777046
28. G Gabbiani GB Ryan J-P Lamelin P Vassalli G Majno CA Bouvier, et al. 1973 Human smooth muscle autoantibody-identification as anti-actin antibody and a study of its binding to 'nonmuscular' cells Am J Pathol 72 473 488 1:STN:280:DyaE3s3ksl2isA%3D%3D 4125700
29. K Lidman G Biberfeld A Fagraeus R Norberg R Torstensson G Utter, et al. 1976 Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis Clin Exp Immunol 24 266 272 1:STN:280:DyaE283gvV2gsg%3D%3D 945140
30. BH Toh 1979 Smooth muscle autoantibodies and autoantigens Clin Exp Immunol 38 621 628 1:STN:280:DyaL3c7jtlSntA%3D%3D 93995
31. Toh B-H, Taylor R, Pollock W, Dearden S, Gill C, Buchner C, Burlingame R. F-actin cell line but not ELISA discriminates "actin-reactive" from "non-actin-reactive" smooth muscle antibody. Pathology. 2010;42:463-9.
32. M Rizzetto G Swana D Doniach 1973 Microsomal antibodies in active chronic hepatitis and other disorders Clin Exp Immunol 15 331 344 1:STN:280: DyaE2c%2FmtVersg%3D%3D 4587503
33. F Alvarez O Bernard JC Homberg G Kreibich 1985 Anti liver kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum J Exp Med 161 1231 1236 1:CAS:528:DyaL2MXktVCks74%3D 10.1084/jem.161.5.1231 3989471 (Pubitemid 15011338)
34. J-C Homberg N Abuaf O Bernard F Alvarez SH Khalil R Poupon, et al. 1987 Chronic active hepatitis with antiliver/kidney microsome antibody type 1: a second type of autoimmune hepatitis Hepatology 7 1333 1339 1:STN:280: DyaL1c%2Fls1Oktw%3D%3D 10.1002/hep.1840070626 3679093 (Pubitemid 18014211)
35. MP Manns EF Johnson KJ Griffin EM Tan KF Sullvan 1989 Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db J Clin Invest 83 1066 1072 1:CAS:528:DyaL1MXhvFShu7g%3D 10.1172/JCI113949 2466049
36. Y Ma DP Bogdanos MJ Hussain J Underhill S Bansal MS Longhi, et al. 2006 Polyclonal T cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2 Gastroenterology 130 868 882 1:CAS:528:DC%2BD28XjsVyltrY%3D 10.1053/j.gastro.2005.12.020 16530525 (Pubitemid 43374534)
37. P Lapierre I Djilali-saiah S Vitozzi F Alvarez 2004 A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens Hepatology 39 1066 1074 1:CAS:528:DC%2BD2cXjtlCqs7o%3D 10.1002/hep.20109 15057911 (Pubitemid 38428946)
38. Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol. 32 Suppl 1:181-97.
39. T Kevenbeck AW Lohse JA Grötzinger 2001 A conformational approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas Hepatology 34 230 233
40. E Martin N Abauf F Cavalli V Durand C Johanet J,-C Homberg 1988 Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2 Hepatology 18 1662 1666 10.1002/hep.1840080632 (Pubitemid 19021905)
41. P Lapierre C Johanet F Alvarez 2003 Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis Eur J Immunol 33 1869 1878 1:CAS:528:DC%2BD3sXlslWlsLg%3D 10.1002/eji.200323857 12811847 (Pubitemid 37120858)
42. Last PM. The treatment of active chronic infectious hepatitis with ACTH (corticotrophin) and cortisone. Med J Aust. 1957;i:672-6.
43. AG Bearn HG Kunkel RJ Slater 1956 The problem of chronic liver disease in young women Am J Med 21 3 15 1:STN:280:DyaG28%2Fpt1Cqtw%3D%3D 10.1016/0002-9343(56)90003-1 13339808
44. O'Brien EN, Goble AJ, Mackay IR. Plasma-transaminase activity as an index of the effectiveness of cortisone in chronic hepatitis. Lancet. 1958;i:1245-9.
45. Mackay IR, Weiden S, Ungar B. The treatment of active chronic hepatitis and lupoid hepatitis with 6-mercaptopurine and azathioprine. Lancet. 1964;i:899-902.
46. IR Mackay 1968 Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone Q J Med 37 379 392 1:STN:280:DyaF1cvgvFOjtQ%3D%3D 4175634
47. GC Cook R Mulligan S Sherlock 1971 Controlled prospective trial of corticosteroid therapy in active chronic hepatitis Q J Med 40 159 185 1:STN:280:DyaE3M3jsVShtA%3D%3D 4933363
48. AJ Czaja GL Davis J Ludwig HF Taswell 1984 Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis Hepatology 4 622 627 1:STN:280:DyaL2c3mt1ynsQ%3D%3D 10.1002/hep.1840040409 6745850
49. G Klatskin 1958 Subacute hepatic necrosis and postnecrotic cirrhosis due to anicteric infections with the hepatitis virus Am J Med 25 333 358 1:STN:280:DyaG1M%2FgtVGksg%3D%3D 10.1016/0002-9343(58)90072-X 13571247
50. JFR Kerr 1971 Shrinkage necrosis: a distinct mode of cellular death J Pathol 105 13 20 1:STN:280:DyaE38%2FmvVyhug%3D%3D 10.1002/path.1711050103 4108566
51. J Searle BV Harmon CJ Bishop JFR Kerr 1987 Significance of single cell death by apoptosis in hepatobiliary disease J Gastroenterol Hepatol 2 77 96 10.1111/j.1440-1746.1987.tb00152.x
52. H Popper F Paronetto F Schaffner 1965 Immune processes in the pathogenesis of liver disease Ann N Y Acad Sci 124 781 799 1:STN:280: DyaF28%2FjslahsQ%3D%3D 10.1111/j.1749-6632.1965.tb19001.x 5214839
53. International Group of Pathologists 1977 Acute and chronic hepatitis revisited Lancet 310 914 919 10.1016/S0140-6736(77)90845-5
54. Whittingham S, Mackay IR, Thanabalasundrum RS, Chuttani HK, Manjuran R, Seah CS, et al. Chronic liver disease: differences in autoimmune serological reactions between Australians and Asians. Br Med J. 1973;iv:517-9.
55. BS Blumberg DA Gerstley DA Hungerford WT London AT Sutnick 1967 A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis Ann Intern Med 66 924 931 1:STN:280:DyaF2s7mtFWktQ%3D%3D 4225883
56. AM Prince 1968 An antigen detected in the blood during the incubation period of serum hepatitis Proc Natl Acad Sci USA 60 814 821 1:STN:280: DyaF1czmsFWqtA%3D%3D 10.1073/pnas.60.3.814 4970112
57. IR Mackay 1972 The prognoses of chronic hepatitis Ann Intern Med 77 649 651 1:STN:280:DyaE3s%2FmsFGqug%3D%3D 4642745
58. JS Pedersen BH Toh IR Mackay BD Tait ID Gust A Kastelan N Hadzic 1982 Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments, with two types of chronic active hepatitis Clin Exp Immunol 48 527 532 1:STN:280:DyaL3s%2Fgt1ektQ%3D%3D 6749349
59. F Alvarez PA Berg FB Bianchi AK Burroughs EL Cancado RW Chapman, et al. 1999 International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 929 938 1:STN:280: DC%2BD3c%2Fks1Ggug%3D%3D 10.1016/S0168-8278(99)80297-9 10580593 (Pubitemid 29514229)
60. EM Hennes M Zeniya A Czaja A Pares GN Dalekos EL Krawitt, et al. 2008 Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 169 176 10.1002/hep.22322 18537184 (Pubitemid 351975541)
61. D Vergani F Alvarez FB Bianchi ELR Cancado IR Mackay MP Manns, et al. 2004 Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group J Hepatol 41 1 7 10.1016/j.jhep.2004.08.002 (Pubitemid 39297806)
62. A Czaja 2008 Performance parameters of the diagnostic scoring systems for autoimmune hepatitis Hepatology 48 1540 1548 10.1002/hep.22513 18924244
63. Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, et al. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology. 2009;50:538-45.
64. Zeniya M. Diagnostic criteria of AIH. Nihon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol). 2010;107 Suppl:A57.
65. IR Mackay 2009 Clustering and commonalities among autoimmune diseases J Autoimmun 33 170 177 1:CAS:528:DC%2BD1MXhsVensLfP 10.1016/j.jaut.2009.09.006 19837564
66. KH Meyer zum Büschenfelde TH Hütteroth M Manns B Möller 1980 The role of liver membrane antigens as targets in autoimmune type liver disease Springer Semin Immunopathol 3 1980 297 315 10.1007/BF02054106 7022712 (Pubitemid 11221511)
67. FV Chisari 1980 Liver-specific protein in perspective Gastroenterology 78 168 170 1:STN:280:DyaL3c%2FntVWhtQ%3D%3D 6153072
68. IG McFarlane B McFarlane GN Major P Tolley R Williams 1984 Identification of the hepatic-receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP) Clin Exp Immunol 55 347 354 1:CAS:528: DyaL2cXhvFSit74%3D 6199139
69. U Treichel B McFarlane T Seki E Krawitt N Alissi F Stickel, et al. 1994 Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis Gastroenterology 107 799 804 1:STN:280:DyaK2czlslekuw%3D%3D 8076767
70. F Tahiri F Le Naour S Huguet R Lai-Kuen S Didier C Johanet, et al. 2008 Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool Hepatology 47 937 948 1:CAS:528:DC%2BD1cXktVOhs7o%3D 10.1002/hep.22149 18306218 (Pubitemid 351449685)
71. Mackay IR, Martinez-Neira R, Whittingham S, Nicolau D, Toh B-H. Autoantigenicity of actin. In: dos Remedios C, Chhabra D, editors. Actin, actin-binding proteins and disease. New York: Springer; 2007. p. 50-64.
72. Mackay IR, Morris PJ. Association of autoimmune chronic hepatitis with HLA1,8. Lancet. 1972;ii:793-5.
73. IR Mackay BD Tait 1980 HLA associations with autoimmune type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies Gastroenterology 79 95 98 1:STN:280:DyaL3c3gt1Cqtg%3D%3D 7380229
74. AJ Czaja PT Donaldson 2000 Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis Immunol Rev 174 250 259 1:CAS:528:DC%2BD3cXjtVygs7s%3D 10.1034/j.1600-0528.2002.017401.x 10807521
75. PT Donaldson DG Doherty KM Hayllar IG McFarlane PJ Johnson R Williams 1991 Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors Hepatology 13 701 706 1:STN:280:DyaK3M7osVOhtg%3D%3D 10.1002/hep.1840130415 2010165
76. JH Reed MW Jackson TP Gordon 2008 A B cell apotope of Ro 60 in systemic lupus erythematosus Arthritis Rheum 58 1125 1129 10.1002/art.23377 18383373 (Pubitemid 351564015)
77. Davies JM (Co-coordinator, Multiauthor Review). Molecular mimicry. Cell Mol Life Sci. 2000;57:723-58.
78. S Vento L Guella F Mirandola F Cainelli G Di Perri M Solbiati, et al. 1995 Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals Lancet 346 608 609 1:STN:280:DyaK2MznvFemtg%3D%3D 10.1016/S0140-6736(95)91438-2 7651006
79. Mackay IR. Gastrointestinal: liver. In: Lahita RG, editor. Systemic lupus erythematosus. 5th ed. London: Elsevier Academic; 2011. p. 865-86.
80. Mackay IR. Immune mechanisms and liver toxicity. In: Cameron RG, Feuer G, de la Inglesia FA, editors. Handbook of experimental pharmacology series: drug-induced hepatotoxicity. Berlin: Springer; 1996. p. 221-47.
81. IR Mackay 2005 The etiopathogenesis of autoimmunity Semin Liver Dis 25 239 250 10.1055/s-2005-916330 16143941 (Pubitemid 41254573)
82. Biburger M, Tiegs G. Animal models of autoimmune liver disease. In: Gershwin ME, Vierling JM, Manns MP, editors. Liver immunology. Principles and practice. 2nd ed. Totowa NJ: Humana; 2007. p. 293-308.
83. Watanabe N. Regulatory T cells and PD-1-mediated signaling in AIH. Nihon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol). 2010;107 Suppl:A54.
84. Lleo A, Shimoda S, Ishibashi H, Gershwin ME. Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol. 2010. doi: 10.1007/s00535-010-0303-8.
85. GF Johnson DA Zawie SR Gilbertson I Sternlieb 1982 Chronic active hepatitis in Doberman pinschers J Am Vet Med Assoc 180 1438 1442 1:STN:280:DyaL383jvV2lsg%3D%3D 7096184